Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Radiother Oncol ; 55(1): 41-7, 2000 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10788687

RESUMO

BACKGROUND: Increasing the radiation dose to prostatic adenocarcinoma has provided higher local control rates. A total of 80 Gy seem necessary to achieve this goal but patient set-up and prostate motion remain difficult problems to solve in conformal radiotherapy. Brachytherapy which overcomes these points could be an alternative way to external beam boost fields. We wanted to transpose the irradiation models largely used in cervix cancer treatment combining external beam radiotherapy and low dose rate brachytherapy. MATERIALS AND METHODS: In 71 patients with 19.5 and 13 ng/ml mean and median PSA levels, respectively, a dose escalation from 74 to 85 Gy was performed in four groups. RESULTS: Shifting from intraoperative placement of sources vectors (Group I) to positioning under ultrasound controls (groups II-IV), improving the implantation shape and optimizing radiation delivery to urethral bed have reduced the total dose to rectal wall under 65 Gy and to urethra under 100 Gy. Rectal/prostate dose ratio was lowered from 0.7 (Groups I-II) to 0.58 (Groups III-IV) while avoiding problems resulting from pelvic bone arch interference, prostate volume or seminal vesicles location. The mean and median follow-up periods are 28 and 18 months. In Groups III and IV 85% of patients without hormonotherapy treated with 80-85 Gy normalized PSA under 1 ng/ml within 6 months. No severe late effect has been noted for patients implanted under echographic control. CONCLUSIONS: The method described allows to deliver 85 Gy. Longer follow-up is however needed but the levels of dose delivered are not expected to induce prohibitive side effects.


Assuntos
Adenocarcinoma/radioterapia , Braquiterapia , Radioisótopos de Irídio/uso terapêutico , Neoplasias da Próstata/radioterapia , Compostos Radiofarmacêuticos/uso terapêutico , Idoso , Análise de Variância , Antineoplásicos Hormonais/uso terapêutico , Braquiterapia/efeitos adversos , Braquiterapia/instrumentação , Quimioterapia Adjuvante , Distribuição de Qui-Quadrado , Estudos de Viabilidade , Seguimentos , Humanos , Cuidados Intraoperatórios , Radioisótopos de Irídio/administração & dosagem , Radioisótopos de Irídio/efeitos adversos , Masculino , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/prevenção & controle , Ossos Pélvicos/efeitos da radiação , Próstata/efeitos da radiação , Antígeno Prostático Específico/análise , Compostos Radiofarmacêuticos/administração & dosagem , Compostos Radiofarmacêuticos/efeitos adversos , Dosagem Radioterapêutica , Radioterapia Conformacional , Reto/efeitos da radiação , Glândulas Seminais/efeitos da radiação , Ultrassonografia de Intervenção , Uretra/efeitos da radiação
3.
Acta Urol Belg ; 66(1): 29-33, 1998 Mar.
Artigo em Francês | MEDLINE | ID: mdl-9611357

RESUMO

We report the case of a 25 year-old man presenting Reiter's syndrome (urethritis, conjunctivitis and oligoarthritis). This clinical triad is a particular expression of reactive arthritis. A genital or enteric infection can be responsible for the onset. Presence of HLA B27 histocompatibility antigen is a genetic factor favoring the development of Reiter's syndrome. Many organs or systems can be affected. In addition to eradication of the initiating infection, treatment is mainly symptomatic and management is multidisciplinary.


Assuntos
Artrite Reativa/diagnóstico , Adulto , Antibacterianos/uso terapêutico , Anti-Infecciosos/uso terapêutico , Anti-Inflamatórios não Esteroides/uso terapêutico , Artrite Reativa/tratamento farmacológico , Artrite Reativa/imunologia , Artrite Reativa/microbiologia , Ciprofloxacina/uso terapêutico , Doxiciclina/uso terapêutico , Enterobacter cloacae , Infecções por Enterobacteriaceae/diagnóstico , Predisposição Genética para Doença , Antígeno HLA-B27/genética , Humanos , Masculino , Piroxicam/uso terapêutico , Infecções Estreptocócicas/diagnóstico , Streptococcus agalactiae
4.
Acta Urol Belg ; 64(3): 37-41, 1996 Sep.
Artigo em Francês | MEDLINE | ID: mdl-8984855

RESUMO

The liposarcoma is mainly located in the retroperitoneum and rarely involves the spermatic cord. Dissemination occurs more often via haematogenous way than by lymphatic way. The incidence of local recurrence is higher than distant metastases. The treatment of choice is the wide excision. Adjuvant radiotherapy is recommended in the well differentiated and myxoid type of tumors if the local control during excision is not complete or wide enough. Benefit of chemotherapy is still controversial and limited. Case report of a stage 1 liposarcoma of the spermatic cord, four years after excision of a large lipoma during a hernia repair. The treatment consisted in radical excision of this liposarcoma without any adjuvant therapy. Follow-up of 30 months without recurrence.


Assuntos
Neoplasias dos Genitais Masculinos/patologia , Lipossarcoma/patologia , Adulto , Neoplasias dos Genitais Masculinos/diagnóstico por imagem , Neoplasias dos Genitais Masculinos/cirurgia , Humanos , Lipossarcoma/diagnóstico por imagem , Lipossarcoma/cirurgia , Masculino , Orquiectomia/métodos , Tomografia Computadorizada por Raios X
5.
J Urol ; 147(4): 1106-7, 1992 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-1552599

RESUMO

Glans hyperemia after penile revascularization is a well known complication normally treated by surgery. However, this reintervention is often difficult due to local fibrosis. We report a case of successful embolization after supra-selective catheterization of the deep dorsal vein through the surgical anastomosis.


Assuntos
Embolização Terapêutica/métodos , Hiperemia/terapia , Doenças do Pênis/terapia , Anastomose Cirúrgica/efeitos adversos , Cateterismo/instrumentação , Embolização Terapêutica/instrumentação , Disfunção Erétil/cirurgia , Humanos , Hiperemia/etiologia , Masculino , Pessoa de Meia-Idade , Doenças do Pênis/etiologia , Pênis/irrigação sanguínea , Veias/cirurgia
6.
Acta Urol Belg ; 60(2): 131-41, 1992.
Artigo em Francês | MEDLINE | ID: mdl-1414729

RESUMO

The authors are reporting the case of a 74 year old man, presenting a renal artery aneurysm. Regarding clinical aspects, medical treatment was elected. The most frequent cause of renal infarct is embolisation arising from the heart, followed by large vessels emboli that are more exceptional. Embolisation arising from the renal artery aneurysms is not very common. Unless contra-indications, surgical cure of the aneurysm is necessary, except those that are non complicated, with a diameter of less than 1.5 cm.


Assuntos
Aneurisma/complicações , Infarto/etiologia , Rim/irrigação sanguínea , Artéria Renal , Idoso , Aneurisma/diagnóstico , Aneurisma/tratamento farmacológico , Diagnóstico por Imagem , Humanos , Infarto/tratamento farmacológico , Masculino , Inibidores da Agregação Plaquetária/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...